QuidelOrtho (QDEL) Insider Ann Rhoads Buys 369 Shares

Ann Rhoads Purchases QuidelOrtho Shares

Ann Rhoads acquired 369 shares of QuidelOrtho Corporation (NasdaqGS: QDEL) on June 25, 2026. The purchase adds to personal holdings in the medical device maker, following a series of similar transactions by other insiders at the firm during the same period.

Stock Valuation and Recent Trading Range

The stock recently changed hands at $13.79 on Tuesday. That price sits below the 50-day moving average of $14.79 and under the 200-day moving average of $18.77. Shares have traded between a 52-week low of $9.92 and a 52-week high of $35.58. The company carries a forward P/E ratio of 7.53, giving market watchers a baseline for its expected future earnings.

Inside the Recent Insider Activity

The transaction on June 25, 2026, arrived alongside purchases by several other company insiders. Wilkins Joseph JR. increased holdings by acquiring 15,532 shares on June 25, 2026. Kenneth Buechler picked up 3,661 shares on the exact same date. Kenneth Widder also added to a personal stake by buying 1,997 shares on June 25, 2026. Polan Mary Lake Ph rounded out the group by purchasing 15,532 shares on June 25, 2026.

Analysts Set New Price Targets

Wall Street firms have recently updated outlooks on the healthcare company. On July 8, 2026, Citigroup maintained its Neutral rating on the shares while lifting its price target to $18.00. Earlier, on July 1, 2026, JP Morgan kept an Underweight rating on the stock while raising its price target to $12.00. Across the broader analyst community, the stock holds a consensus mean price target of $14.67 based on three opinions.

Inside QuidelOrtho Corporation's Business

QuidelOrtho Corporation provides diagnostic testing solutions across global markets. The San Diego, California-based firm operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. It sells clinical chemistry instruments, immunoassay products, blood typing tools, and molecular diagnostic kits directly to hospitals, reference laboratories, and healthcare providers.

Looking Ahead to November Earnings

Investors will watch for updated financial metrics when QuidelOrtho Corporation releases its next earnings report on November 5, 2026. Market participants will monitor revenue growth and profit margins to see how the medical device provider performs in coming quarters.